Cargando…
Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality
COVID-19 medicines, such as molnupiravir are beginning to emerge for public health and clinical practice. On the other hand, drugs display marked variability in their efficacy and safety. Hence, COVID-19 medicines, as with all drugs, will be subject to the age-old maxim “one size prescription does n...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576910/ https://www.ncbi.nlm.nih.gov/pubmed/36265833 http://dx.doi.org/10.1016/j.pupt.2022.102172 |